Medipal Holdings Corp
TSE:7459

Watchlist Manager
Medipal Holdings Corp Logo
Medipal Holdings Corp
TSE:7459
Watchlist
Price: 2 781.5 JPY 0.11% Market Closed
Market Cap: ¥575.7B

Medipal Holdings Corp
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Medipal Holdings Corp
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Medipal Holdings Corp
TSE:7459
Free Cash Flow
¥34.1B
CAGR 3-Years
44%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
A
Alfresa Holdings Corp
TSE:2784
Free Cash Flow
¥8.3B
CAGR 3-Years
58%
CAGR 5-Years
-22%
CAGR 10-Years
-1%
Toho Holdings Co Ltd
TSE:8129
Free Cash Flow
¥4B
CAGR 3-Years
-32%
CAGR 5-Years
-27%
CAGR 10-Years
-7%
Suzuken Co Ltd
TSE:9987
Free Cash Flow
¥1.5B
CAGR 3-Years
-40%
CAGR 5-Years
-48%
CAGR 10-Years
-21%
Ship Healthcare Holdings Inc
TSE:3360
Free Cash Flow
¥21.1B
CAGR 3-Years
16%
CAGR 5-Years
29%
CAGR 10-Years
11%
As One Corp
TSE:7476
Free Cash Flow
¥6.5B
CAGR 3-Years
1%
CAGR 5-Years
28%
CAGR 10-Years
5%
No Stocks Found

Medipal Holdings Corp
Glance View

Market Cap
575.7B JPY
Industry
Health Care

Medipal Holdings Corp., a longstanding pillar in Japan’s healthcare and pharmaceutical distribution network, tells a story of efficiency and dedication to health. Born from a strategic merger in the late 20th century, Medipal has established itself as a key player in the intricate world of pharmaceutical and medical supply logistics. The company's operations are woven into the fabric of Japan’s healthcare infrastructure, where precision and reliability form the foundation of its success. By orchestrating the smooth flow of pharmaceuticals, medical devices, and health-related products from manufacturers to a myriad of healthcare facilities and retail outlets, Medipal plays a vital role in ensuring that medical professionals and patients alike have timely access to necessary products. At the heart of Medipal's business model is a comprehensive supply chain that seamlessly connects an extensive network of partners. With sophisticated distribution centers operating as logistical powerhouses, Medipal leverages cutting-edge technology to optimize inventory management and delivery systems. This enables the company not only to drive efficiencies but also to create value by reducing costs and enhancing the speed and reliability of distributions. Revenue streams are generated primarily through distribution fees and the strategic management of logistics services. As Medipal continues to expand its reach and refine its operations, it remains steadfast in its commitment to being an indispensable ally in Japan's healthcare landscape, where reliability and trust are of paramount importance.

Intrinsic Value
4 625.98 JPY
Undervaluation 40%
Intrinsic Value
Price ¥2 781.5

See Also

What is Medipal Holdings Corp's Free Cash Flow?
Free Cash Flow
34.1B JPY

Based on the financial report for Dec 31, 2025, Medipal Holdings Corp's Free Cash Flow amounts to 34.1B JPY.

What is Medipal Holdings Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-10%

Over the last year, the Free Cash Flow growth was -40%. The average annual Free Cash Flow growth rates for Medipal Holdings Corp have been 44% over the past three years , -10% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett